ヘルス02 2月, 2017

Sentri7 from Wolters Kluwer earns Category Leader Designation for Clinical Decision Support-Surveillance in the 2017 Best in KLAS report

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that its Sentri7® solution has received the 2017 Category Leader award for Clinical Decision Support-Surveillance in the 2017 Best in KLAS: Software & Services report. Having captured the Category Leader designation in two previous Best in KLAS reports, the clinical surveillance and decision support platform was awarded top honors for: general satisfaction; functionality and upgrades; and sales and contracting.

Utilizing algorithms to prevent bias, KLAS partners with healthcare providers to provide insight into the quality of healthcare technology solutions. Based on the aggregated feedback of thousands of healthcare professionals and clinicians, the Best in KLAS annual report recognizes the best-performing healthcare IT vendors in more than 100 market segments to ultimately improve vendor performance and guide healthcare provider buying decisions.

Sentri7 drives continuous improvement by leveraging EMR investments to empower clinicians to operate smarter and more efficiently. An interoperable SaaS platform, the HIPAA-compliant clinical decision support surveillance solution provides real-time aggregation of patient data to automate tracking, identification and reporting of patient issues to enable proactive governance and management of critical clinical initiatives such as Antimicrobial Stewardship. Sentri7 clinical content is created and maintained by clinicians and put through a rigorous editorial process that synthesizes the most up-to-date medical information into accurate, trusted, evidence-based alerts and care recommendations designed to achieve important clinical outcomes.

“Hospitals and healthcare organizations are increasingly turning towards clinical surveillance solutions to comply with federal and state regulations, as well as transition to value-based care,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “It is a great honor to have Sentri7 once again recognized by our customers through KLAS as an impactful intervention that aids in providing optimal care.”

ウォルターズ・クルワーについて
ウォルターズ・クルワー(WKL:Wolters Kluwer)は、医療、税務・会計、ガバナンス、リスク管理とコンプライアンス、法規制の部門に向けた専門的情報、ソフトウェアソリューションとサービスのグローバルリーダーです。深い専門知識と特殊技術・サービスを一つにした専門的ソリューションを提供して、顧客が日々の重要な意思決定を行えるようにします。
ウォルターズ・クルワーは、2020年の収益を46億ユーロと報告しました。同グループは180か国以上の顧客にサービスを提供し、40か国以上に業務を展開、世界中で約1万9200人を雇用しています。同社はオランダのアルフェン・アーン・デン・レインに本部を置いています。
ウォルターズ・クルワーはユーロネクスト・アムステルダム(Euronext Amsterdam)に上場しており(WKL)、AEXとユーロネクスト100株価指数(Euronext 100 indices)に含まれています。ウォルターズ・クルワーはレベル1米国預託証券(ADR:American Depositary Receipt)プログラムのスポンサーを務めました。ADRは米国の店頭取引市場で取引されています(WTKWY)。
 
Back To Top